A by-election called back in January took place Wednesday night in Outlook. The ballots have been counted, and with 100 more ...
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced the pricing of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results